Loading
Latest filing published 04 Mar 2025 for Cytosorbents Corp, €11k.
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Michael G. Bator, listed as board member, appears in our data through filings on Cytosorbents Corp shares, published by SEC (Form 4). Over a trading history stretching from 2 June 2016 to 24 February 2025, the count stands at 14 filings.
No open-market sale appears; the market trades are 7 purchases worth €78k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 6 share grants.
Half of the purchases are above €4,163 and half below. Of 5 purchases, 2 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. After 6 purchases with a full 90-day history, the hit rate stands at 17% and the median 90-day move at -53.6%. Past outcomes like these are no guarantee of what comes next.
The newest entry dates from 4 March 2025: a transaction of €11k, in Cytosorbents Corp. The last insider purchase was made public on 15 December 2023, 1,044 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations